EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer

Jing Zhang, Ji Guo, Ruochong He, Ji Li, Bingyi Du, Yi Zhang, Rongliang He, Haixia Cheng

International Journal of Colorectal Disease · 07.04.2024 · 39 (1)

DOI: 10.1007/s00384-024-04617-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 07.04.2024. Verfasst von Jing Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Shanxi Bethune Hospital, Xiaodian District, No. 99 of Longcheng Street, Taiyuan, 030032, China. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Program of Shanxi Province, Shanxi Province“136”Revitalization Medical Project Construction Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In this study, we investigated the impact of perioperative administration of Bifidobacterium triplex viable capsules on the serum levels of circulating miR-21-5p, miR-135-5p, and miR-155-5p in patients with colorectal cancer (CRC). The purpose of this study is to provide a foundation for future research on the use of Bifidobacterium triplex viable capsules to enhance postoperative recovery in patients with CRC.

Methods

A total of 60 patients with primary CRC admitted to the Department of General Surgery at Shanxi Bethune Hospital between June 2020 and December 2020 were selected and randomly divided into two groups: 20 cases in the control group and 40 cases in the experimental group. The experimental group was administered oral Bifidobacterium triplex viable capsules during the perioperative period, while the control group was administered oral placebo. Before and after the perioperative period, the expression levels of miR-21-5p, miR-135-5p, and miR-155-5p were compared in the serum of both groups of patients. Furthermore, we established the prognostic value of these three miRNAs in CRC patients.

Results

After surgery, the expression levels of miR-21-5p, miR-135-5p, and miR-155-5p decreased in both groups of patients ( P < 0.05). Significantly greater differences were observed between miR-21-5p and miR-135-5p ( P < 0.001). Expression levels of serum miR-21-5p ( P = 0.020) and miR-135-5p ( P = 0.023) decreased significantly more in the experimental group than in the control group. The levels of the above three miRNAs after surgery did not correlate with 3-year OS (HR = 4.21; 95% CI 0.37–47.48; log-rank P = 0.20) or 3-year DFS (HR = 1.57; 95% CI 0.32–7.66; log-rank P = 0.55) in two groups.

Conclusion

Radical surgery reduces the levels of serum miR-21-5p, miR-135-5p, and miR-155-5p expression in patients with CRC. The use of Bifidobacterium triplex viable capsules assists in achieving quicker perioperative recovery from radical surgery in CRC patients, and this underlying mechanism may be associated with the regulation of serum miR-21-5p, miR-135-5p, and miR-155-5p expression levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsColorectal NeoplasmsHumansPrognosisGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

Bifidobacterium triplex viable capsulesColorectal cancerPerioperative periodmiR-135-5pmiR-155-5pmiR-21-5p

Substanzen

MicroRNAsMIRN135 microRNA, humanMIRN155 microRNA, humanMIRN21 microRNA, human

Autor:innen und Institutionen

  • Department of General Surgery, Shanxi Bethune Hospital, Xiaodian District, No. 99 of Longcheng Street, Taiyuan, 030032, China.
  • Second Department of General Surgery, Shanxi Provincial Integrated TCM And WM Hospital, Taiyuan, 030013, China.
  • Department of General Surgery, Xiaoyi People's Hospital of Shanxi Province, Luliang, 032300, China.
  • Department of General Surgery, Shanxi Bethune Hospital, Xiaodian District, No. 99 of Longcheng Street, Taiyuan, 030032, China. haixiachengchx@126.com.

Förderung

  • Fundamental Research Program of Shanxi Province
  • Shanxi Province“136”Revitalization Medical Project Construction Funds

Zitieren

APA

Zhang, J., Guo, J., He, R., Li, J., Du, B., Zhang, Y., He, R., & Cheng, H. (2024). Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer. International Journal of Colorectal Disease, 39(1). https://doi.org/10.1007/s00384-024-04617-8

Vancouver

Zhang J, Guo J, He R, Li J, Du B, Zhang Y, et al. Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer. International Journal of Colorectal Disease. 2024;39(1). doi:10.1007/s00384-024-04617-8

BibTeX
@article{Zhang2024,
  author = {Zhang, Jing and Guo, Ji and He, Ruochong and Li, Ji and Du, Bingyi and Zhang, Yi and He, Rongliang and Cheng, Haixia},
  title = {Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer},
  journal = {International Journal of Colorectal Disease},
  year = {2024},
  volume = {39},
  number = {1},
  doi = {10.1007/s00384-024-04617-8}
}
Kostenlos starten →